Human Genome Epidemiology Literature Finder
|
Records 1 - 28 (of 28 Records) |
| Query Trace: Ovarian Neoplasms and GSTP1[original query] |
|---|
| Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent results in cancer research. Fortschritte der Krebsforschung. Progre?s dans les recherches sur le cancer 1998 154 47-85. Hengstler J G, Arand M, Herrero M E, Oesch |
| Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001 Jan 22 (1): 67-72. Spurdle A B, Webb P M, Purdie D M, Chen X, Green A, Chenevix-Trench |
| Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genetics in medicine : official journal of the American College of Medical Genetics 0 4 (4): 250-7. Coughlin Steven S, Hall Ingrid |
| GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1823-7. Moore Lee E, Huang Wen-Yi, Chatterjee Nilanjan, Gunter Marc, Chanock Stephen, Yeager Meredith, Welch Bob, Pinsky Paul, Weissfeld Joel, Hayes Richard |
| Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecologic oncology 2006 Feb 100 (2): 330-7. Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu |
| Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. Journal of cancer research and clinical oncology 2006 Aug 132 (8): 521-8. Morari Elaine Cristina, Lima Andre Bacellar Costa, Bufalo Natassia Elena, Leite Janaina Luisa, Granja Fabiana, Ward Laura Steri |
| The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. European journal of cancer (Oxford, England : 1990) 2007 Jan 43 (2): 283-90. Nagle Christina M, Chenevix-Trench Georgia, Spurdle Amanda B, Webb Penelope |
| Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35. Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe |
| Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. British journal of cancer 2008 Jun 98 (12): 2006-10. Kadouri L, Kote-Jarai Z, Hubert A, Baras M, Abeliovich D, Hamburger T, Peretz T, Eeles R |
| Association between genetic polymorphisms and ovarian cancer risk. Anticancer research 0 28 (5B): 3079-81. Delort Laetitia, Chalabi Nasséra, Satih Samir, Rabiau Nadège, Kwiatkowski Fabrice, Bignon Yves-Jean, Bernard-Gallon Dominique |
| Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. The pharmacogenomics journal 2010 Feb 10 (1): 54-61. Khrunin A V, Moisseev A, Gorbunova V, Limborska |
| Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer research 2009 Mar 69 (5): 1877-84. Koutros Stella, Berndt Sonja I, Sinha Rashmi, Ma Xiaomei, Chatterjee Nilanjan, Alavanja Michael C R, Zheng Tongzhang, Huang Wen-Yi, Hayes Richard B, Cross Amanda |
| Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecologic oncology 2009 May 113 (2): 264-9. Kim Hee Seung, Kim Mi-Kyung, Chung Hyun Hoon, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kang Soon Be |
| Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010 Jul 20 (5): 732-7. Economopoulos Konstantinos P, Sergentanis Theodoros N, Vlahos Nikos |
| Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Molecular carcinogenesis 2011 May 50 (5): 397-402. Goode Ellen L, White Kristin L, Vierkant Robert A, Phelan Catherine M, Cunningham Julie M, Schildkraut Joellen M, Berchuck Andrew, Larson Melissa C, Fridley Brooke L, Olson Janet E, Webb Penelope M, Chen Xiaoqing, Beesley Jonathan, Chenevix-Trench Georgia, Sellers Thomas A, , |
| Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics 2011 Dec . Khrunin A, Ivanova F, Moisseev A, Khokhrin D, Sleptsova Y, Gorbunova V, Limborska S |
| [Association of polymorphisms in glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population]. Genetika 2012 Jul 48 (7): 901-4. Khokhrin D V, Khrunin A V, Moiseev A A, Gorbunov V A, Limborskaia S |
| Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk. Disease markers 2012 33 (3): 155-9. Oliveira Cristiane, Lourenço Gustavo Jacob, Sagarra Regina Aparecida Martinho, Derchain Sophie Françoise Mauricette, Segalla José Getulio, Lima Carmen Silvia Pass |
| Lack of any association of GST genetic polymorphisms with susceptibility to ovarian cancer--a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6131-6. Han Li-Yuan, Liu Kui, Lin Xia-Lu, Zou Bao-Bo, Zhao Jin-Sh |
| Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
| Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer. Medical oncology (Northwood, London, England) 2016 Oct 33 (10): 112. Carron Juliana, Brito Angelo Borsarelli Carvalho, Torelli Ana Carolina Mourão, Oliveira Cristiane, Derchain Sophie Françoise Mauricette, Lima Carmen Silvia Passos, Lourenço Gustavo Jac |
| Single nucleotide polymorphisms in glutathione S-transferase P1 and M1 genes and overall survival of patients with ovarian serous cystadenocarcinoma treated with chemotherapy. Oncology letters 2016 Apr 11 (4): 2525-2531. Cong Lan-Xiang, Zhai Xiang-Hong, Wu Feng-Xia, Zhu Dong-Yi, Wang An-Co |
| Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 22 (1): 72-79. Pljesa Igor, Berisavac Milica, Simic Tatjana, Pekmezovic Tatjana, Coric Vesna, Suvakov Sonja, Stamatovic Ljiljana, Matic Marija, Gutic Bojana, Milenkovic Sanja, Pljesa-Ercegovac Marija, Savic-Radojevic A |
| GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes. Oncotarget 2018 Jul 9 (51): 29789-29800. Yoshihama Tomoko, Fukunaga Koya, Hirasawa Akira, Nomura Hiroyuki, Akahane Tomoko, Kataoka Fumio, Yamagami Wataru, Aoki Daisuke, Mushiroda Tais |
| ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 1925-1929. Liblab Salisa, Vusuratana Apichai, Areepium Nuttha |
| MassArray analysis of genomic susceptibility variants in ovarian cancer. Scientific reports 2020 12 10 (1): 21101. Verma Sonali, Sharma Indu, Sharma Varun, Bhat Amrita, Shah Ruchi, Bhat Gh Rasool, Sharma Bhanu, Bakshi Divya, Nagpal Ashna, Wakhloo Ajay, Bhat Audesh, Kumar Rake |
| GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. Clinical and translational science 2020 Dec . Ferracini Amanda Canato, Lopes-Aguiar Leisa, Lourenço Gustavo Jacob, Yoshida Adriana, Lima Carmen Silva Passos, Sarian Luis Otávio, Derchain Sophie, Kroetz Deanna L, Mazzola Priscila Ga |
| Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high-grade serous ovarian cancer. Basic & clinical pharmacology & toxicology 2023 3 . Deng Feng, Laasik Maren, Salminen Liina, Lapatto Lauri, Huhtinen Kaisa, Li Yilin, Hautaniemi Sampsa, Hynninen Johanna, Niemi Mikko, Lehtonen Rain |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: